Researchers observed responses in patients with synovial sarcoma or myxoid/round cell liposarcoma treated with lete-cel.

T therapy targeting p95HER2 shows complete and durable tumor responses in HER2+ breast cancer preclinical models. Combining ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

New advances allow scientists to study DNA, RNA, and gene activity in individual cells rather than in bulk tissue samples.

Santhosh K. Sadashiv, MD, discusses the role of chimeric antigen receptor T-cell therapy in patients with multiple myeloma.

A clinical trial has shown promising results in treating brain tumours in children using an immune-cell therapy known as ...

Well, months after India's drug regulator approved the commercial use of CAR-T cell therapy, a groundbreaking treatment that ...

Research on stem cells is ongoing, but they're approved to treat a certain group of diseases. Here's what doctors say about ...